ARTICLE | Clinical News
Zydelig idelalisib: Phase III data
November 23, 2015 8:00 AM UTC
Gilead said the double-blind, placebo-controlled, U.S. Phase III Study 115 trial in 416 previously treated patients with relapsed CLL will be unblinded early after a pre-defined interim analysis showe...